ASCO: AstraZeneca looks to bring immunotherapy to early-stage stomach cancer with Imfinzi

AstraZeneca’s Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to results from a phase 3 study.

Jun 1, 2025 - 13:35
 0
ASCO: AstraZeneca looks to bring immunotherapy to early-stage stomach cancer with Imfinzi
AstraZeneca’s Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to results from a phase 3 study.